
Keywords: Splicing prediction; Splicing-affecting variants; Cryptic splice sites; Primary immunodeficiencies; ESE; exon splicing enhancer; ESS; exon splicing silencer; NMD; nonsense-mediated decay; SRE; splicing regulatory element; VUS; variants of unknown signific